Background and Aims Many children with primary sclerosing cholangitis (PSC) receive oral
vancomycin therapy (OVT) or ursodeoxycholic acid (UDCA). There is a paucity of data on …

Alanine aminotransferase (ALT) and ultrasound (US) are the most commonly used tools for
detecting non-alcoholic fatty liver disease (NAFLD). No direct comparison of these two …

Objectives: Disturbances in lipid metabolism play an important role in the pathogenesis of
nonalcoholic fatty liver disease (NAFLD). Using lipidomics, an analytical technique that is …

Background and Aims Disease progression in children with primary sclerosing cholangitis (PSC)
is variable. Prognostic and risk‐stratification tools exist for adult‐onset PSC, but not for …

Background & Aims Non‐alcoholic fatty liver disease (NAFLD) has become the most common
chronic liver disease in children. Even at young age, it can progress to liver fibrosis. Given …

Objectives To determine the diagnostic accuracy of controlled attenuation parameter (CAP)
on FibroScan ® in detecting and grading steatosis in a screening setting and perform a head-…

Genome‐wide association studies in adults have identified variants in hydroxysteroid 17‐beta
dehydrogenase 13 (HSD17B13) and mitochondrial amidoxime reducing component 1 (…

Background and Aims Recurrent primary sclerosing cholangitis (rPSC) following liver transplant
(LT) has a negative impact on graft and patient survival; little is known about risk factors …

Objectives: Most patients with primary sclerosing cholangitis (PSC) also have inflammatory
bowel disease (IBD). The liver and colon express MAdCAM‐1, a target of lymphocyte homing …

Methods Data for persons diagnosed with PSC-UC (age, 0–18 y) were collected from 54
centers through the Pediatric PSC Consortium. A full description of the methodology to …